Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 30;45(4):180-192.
doi: 10.14348/molcells.2022.2222.

Regulation of Hepatic Gluconeogenesis by Nuclear Receptor Coactivator 6

Affiliations

Regulation of Hepatic Gluconeogenesis by Nuclear Receptor Coactivator 6

Gyun-Sik Oh et al. Mol Cells. .

Abstract

Nuclear receptor coactivator 6 (NCOA6) is a transcriptional coactivator of nuclear receptors and other transcription factors. A general Ncoa6 knockout mouse was previously shown to be embryonic lethal, but we here generated liver-specific Ncoa6 knockout (Ncoa6 LKO) mice to investigate the metabolic function of NCOA6 in the liver. These Ncoa6 LKO mice exhibited similar blood glucose and insulin levels to wild type but showed improvements in glucose tolerance, insulin sensitivity, and pyruvate tolerance. The decrease in glucose production from pyruvate in these LKO mice was consistent with the abrogation of the fasting-stimulated induction of gluconeogenic genes, phosphoenolpyruvate carboxykinase 1 (Pck1) and glucose-6-phosphatase (G6pc). The forskolin-stimulated inductions of Pck1 and G6pc were also dramatically reduced in primary hepatocytes isolated from Ncoa6 LKO mice, whereas the expression levels of other gluconeogenic gene regulators, including cAMP response element binding protein (Creb), forkhead box protein O1 and peroxisome proliferator-activated receptor γ coactivator 1α, were unaltered in the LKO mouse livers. CREB phosphorylation via fasting or forskolin stimulation was normal in the livers and primary hepatocytes of the LKO mice. Notably, it was observed that CREB interacts with NCOA6. The transcriptional activity of CREB was found to be enhanced by NCOA6 in the context of Pck1 and G6pc promoters. NCOA6-dependent augmentation was abolished in cAMP response element (CRE) mutant promoters of the Pck1 and G6pc genes. Our present results suggest that NCOA6 regulates hepatic gluconeogenesis by modulating glucagon/cAMP-dependent gluconeogenic gene transcription through an interaction with CREB.

Keywords: cAMP response element-binding protein; gluconeogenesis; glucose-6-phosphatase; nuclear receptor coactivator 6; phosphoenolpyruvate carboxykinase.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The authors have no potential conflicts of interest to disclose.

Figures

Fig. 1
Fig. 1. Establishment of liver-specific Ncoa6 knockout mice.
(A) Schematic representation of the liver-specific knockout strategy used for the Ncoa6 gene, based on the Cre-LoxP system. Blue arrows denote the specific primer binding sites for genotyping. (B-D) The liver specific knockout of Ncoa6 was confirmed at the level of genomic DNA (gDNA), mRNA and protein. gDNA and mRNA were isolated from the liver, muscle, kidney and white adipose tissue (WAT) of Ncoa6fl/fl/Cre+/- (LKO) and Ncoa6fl/fl/Cre-/- (F/F) mice. The Ncoa6 gDNA levels were determined by conventional PCR (B). The Ncoa6 mRNA and NCOA6 protein levels were determined by qRT-PCR (C; n = 4) and western blotting (D; n = 3), respectively. mRNA data are presented as the mean ± SEM; ***P < 0.001 by t-test comparisons of the genotypes.
Fig. 2
Fig. 2. Glucose metabolism in Ncoa6 LKO mice.
(A) The blood glucose levels were measured in Ncoa6 LKO (n = 8) and WT (F/F, n = 9) mice after 16 h fasting. (B) Improved glucose tolerance in the Ncoa6 LKO mice. Intraperitoneal glucose tolerance tests were performed in 10-week-old mice (n = 9 for F/F, n = 8 for LKO) after a 16 h fast. (C) The serum insulin levels were measured in Ncoa6 LKO (n = 6 for fed, n = 7 for fasted) and WT mice (n = 7 for both fed and fasted) before and after a 16 h fast. (D) Enhanced insulin sensitivity in Ncoa6 LKO mice. Intraperitoneal insulin tolerance tests were performed in 10-week-old Ncoa6 LKO (n = 13) and WT mice (n = 10) after a 6 h fast. (E) Pyruvate tolerance was determined in 10-week-old Ncoa6 LKO (n = 11) and WT (n = 10) mice via an intraperitoneal injection with pyruvate (2 g/kg body weight) after overnight fasting for 16 h. AUC values for GTT, ITT, and PTT were calculated and are presented on the right of each graph. Data are presented as the mean ± SEM; *P < 0.05, **P < 0.01 by t-test comparisons of the genotypes. WT, wild type; GTT, glucose tolerance test; ITT, insulin tolerance test; PTT, pyruvate tolerance test.
Fig. 3
Fig. 3. Alterations in the gluconeogenic enzyme expression levels in Ncoa6 LKO mice.
(A) Decreased induction of gluconeogenic gene transcripts in the Ncoa6 LKO liver following fasting. Liver RNAs were isolated from Ncoa6 LKO and WT mice after a 24 h fast (n = 6 for each group). The mRNA levels of Pc, Pck1, and G6pc were determined by real-time qRT-PCR. (B) Attenuated induction of PCK protein in the Ncoa6 LKO liver after fasting. Protein expression was analyzed in the liver of ad libitum fed mice and 16 h fasted mice (n = 7 for each group) by western blot analysis. Intensities of the protein bands were measured using the ImageJ program. (C) Glucagon tolerance of Ncoa6 LKO mice (n = 10 for F/F, n = 14 for LKO). Ten-week-old mice were injected intraperitoneally with glucagon (15 µg/kg) after 6 h of fasting. Blood samples were prepared at 0, 30, 60, 90, and 120 min after the glucagon injection. AUC values are shown on the right. (D) Effects of NCOA6 on the glucose production level in primary hepatocytes. Glucose production was compared between Ncoa6 LKO and WT mouse primary hepatocytes after a 4 h forskolin treatment using glucose free media supplemented with lactate and sodium pyruvate (n = 4 independent experiments). (E) Alteration of Pck1 and G6pc transcript induction in Ncoa6 LKO primary hepatocytes following a 4 h treatment of these cells with forskolin (n = 5 independent experiments). Transcript levels were analyzed by real-time qRT-PCR. Data are presented as the mean ± SEM; **P < 0.01, ***P < 0.001, determined using one-way ANOVA. Fsk, forskolin.
Fig. 4
Fig. 4. Gluconeogenic factors and CREB phosphorylation in the Ncoa6 LKO mouse.
(A) Serum glucagon levels in the Ncoa6 LKO (n = 6 for fed, n = 7 for fasted) and WT mice (n = 7 for both fed and fasted) before and after 16 h of fasting. (B) mRNA levels of gluconeogenic transcriptional factors in the liver of Ncoa6 LKO and WT mice in a fed or 24 h fasted state (n = 6 for each group). Hepatic mRNAs were analyzed by real-time qRT-PCR. (C) Transcript levels of the CREB target gene Nr4a1 and FOXO1 target gene Igfbp1 in the primary hepatocytes of Ncoa6 LKO (n = 4) and WT mice (n = 3). (D) Induced phosphorylation of CREB by 16 h of fasting in the livers of Ncoa6 LKO and WT mice (n = 3 for each group). (E) Forskolin-induced phosphorylation of CREB in primary hepatocytes of Ncoa6 LKO and WT mice. Protein levels were determined by western blot analyses using anti-CREB, anti-pCREB (Ser133) or anti-tubulin antibodies (n = 5 independent experiments). The intensities of the protein bands were measured using the ImageJ program. Data are presented as the mean ± SEM; ***P < 0.001, determined using one-way ANOVA. Fsk, forskolin.
Fig. 5
Fig. 5. Transcriptional activation of the Pck1 and G6PC genes by NCOA6.
(A) Interactions between CREB and NCOA6. 293T cells were transfected with HA-CREB and FLAG-NCOA6 and lysates were immunoprecipitated from these cells using anti-HA or anti-FLAG antibody. The coimmunoprecipitates were then analyzed by western blotting with anti-HA or anti-FLAG antibody. (B) Sequence alignment of the CRE-containing promoter regions of the Pck1 or G6pc gene among human, mouse, and rat. (C) Schematic diagram of the rPck1 or hG6PC promoter-Luc reporter containing WT or MT CRE. The red bars indicate the loci of the ChIP primers used in Figs. 6A and 6B. (D and E) Effects of NCOA6 on the CREB-mediated transcriptional activation of the rPck1 (D) and hG6PC (E) promoter (n = 5 independent experiments). WT or MT CRE-containing Pck1 or G6PC promoter-Luc reporters were cotransfected into HepG2 cells with or without HA-CREB, FLAG-NCOA6 and actin-β-galactosidase. Luciferase activities were then measured with a luminometer and normalized using β-galactosidase activities. Data are presented as the mean ± SEM; ***P < 0.001, determined using one-way ANOVA. IP, immunoprecipitation; WT, wild type; MT, mutant; Fsk, forskolin.
Fig. 6
Fig. 6. Recruitment of CREB and NCOA6 to the CRE regions of the Pck1 and G6PC promoter.
(A and B) 293T cells were cotransfected with a Pck1 (A) or G6PC (B) promoter-Luc reporter, HA-CREB and FLAG-NCOA6. Modified ChIP assays were then performed using anti-HA, anti-FLAG or IgG antibodies, followed by analysis using conventional PCR (n = 4 independent experiments). The intensities of the PCR bands were measured using the ImageJ program. Data are presented as the mean ± SEM; *P < 0.05, **P < 0.01, determined by t-test. WT, wild type; MT, mutant; IP, immunoprecipitation. (C) Hypothetical model for the gluconeogenic transcription of the Pck1 and G6pc genes mediated via NCOA6.

Similar articles

Cited by

References

    1. Altarejos J.Y., Montminy M. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat. Rev. Mol. Cell Biol. 2011;12:141–151. doi: 10.1038/nrm3072. - DOI - PMC - PubMed
    1. Antonson P., Schuster G.U., Wang L., Rozell B., Holter E., Flodby P., Treuter E., Holmgren L., Gustafsson J.Å. Inactivation of the nuclear receptor coactivator RAP250 in mice results in placental vascular dysfunction. Mol. Cell. Biol. 2003;23:1260–1268. doi: 10.1128/MCB.23.4.1260-1268.2003. - DOI - PMC - PubMed
    1. Basu R., Chandramouli V., Dicke B., Landau B., Rizza R. Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis. Diabetes. 2005;54:1942–1948. doi: 10.2337/diabetes.54.7.1942. - DOI - PubMed
    1. Benchoula K., Parhar I.S., Madhavan P., Hwa W.E. CREB nuclear transcription activity as a targeting factor in the treatment of diabetes and diabetes complications. Biochem. Pharmacol. 2021;188:114531. doi: 10.1016/j.bcp.2021.114531. - DOI - PubMed
    1. Caira F., Antonson P., Pelto-Huikko M., Treuter E., Gustafsson J.Å. Cloning and characterization of RAP250, a novel nuclear receptor coactivator. J. Biol. Chem. 2000;275:5308–5317. doi: 10.1074/jbc.275.8.5308. - DOI - PubMed

MeSH terms

Substances